Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shih-Shih Chen

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Cancer Immunology Research|July 19, 2019
SLAMF6 as a Regulator of Exhausted CD8<sup>+</sup> T Cells in CancerBurcu Yigit, Ninghai Wang, Elisa Ten Hacken, et al.
Blood Advances|January 4, 2018
Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironmentSara Serra, Tiziana Vaisitti, Valentina Audrito, et al.
JCI Insight|May 10, 2016
Chronic lymphocytic leukemia cells diversify and differentiate in vivo via a nonclassical Th1-dependent, Bcl-6-deficient processPiers E M Patten, Gerardo Ferrer, Shih-Shih Chen, et al.
Haematologica|September 11, 2025
IGLV3-21<sup>R110</sup>-directed bispecific antibodies activate T cells and promote killing in a high-risk subset of chronic lymphocytic leukemiaClaudia Fischer, Shih-Shih Chen, Johanna Nimmerfroh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2023
Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft ModelShih-Shih Chen, Jacqueline C Barrientos, Gerardo Ferrer, et al.
Leukemia|January 28, 2021
Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic targetFlorencia Palacios, Xiao-Jie Yan, Gerardo Ferrer, et al.
Blood|April 24, 2019
IGF1R as druggable target mediating PI3K-δ inhibitor resistance in a murine model of chronic lymphocytic leukemiaAnnika Scheffold, Billy Michael Chelliah Jebaraj, Eugen Tausch, et al.
Haematologica|November 10, 2018
The involvement of microRNA in the pathogenesis of Richter syndromeKatrien Van Roosbroeck, Recep Bayraktar, Steliana Calin, et al.
JCI Insight|February 1, 2017
Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinibJan A Burger, Kelvin W Li, Michael J Keating, et al.
Leukemia|May 3, 2021
Myeloid-derived suppressor cell subtypes differentially influence T-cell function, T-helper subset differentiation, and clinical course in CLLGerardo Ferrer, Byeongho Jung, Pui Yan Chiu, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Cancer Immunology Research|July 19, 2019
SLAMF6 as a Regulator of Exhausted CD8<sup>+</sup> T Cells in CancerBurcu Yigit, Ninghai Wang, Elisa Ten Hacken, et al.
Blood Advances|January 4, 2018
Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironmentSara Serra, Tiziana Vaisitti, Valentina Audrito, et al.
JCI Insight|May 10, 2016
Chronic lymphocytic leukemia cells diversify and differentiate in vivo via a nonclassical Th1-dependent, Bcl-6-deficient processPiers E M Patten, Gerardo Ferrer, Shih-Shih Chen, et al.
Haematologica|September 11, 2025
IGLV3-21<sup>R110</sup>-directed bispecific antibodies activate T cells and promote killing in a high-risk subset of chronic lymphocytic leukemiaClaudia Fischer, Shih-Shih Chen, Johanna Nimmerfroh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2023
Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft ModelShih-Shih Chen, Jacqueline C Barrientos, Gerardo Ferrer, et al.
Leukemia|January 28, 2021
Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic targetFlorencia Palacios, Xiao-Jie Yan, Gerardo Ferrer, et al.
Blood|April 24, 2019
IGF1R as druggable target mediating PI3K-δ inhibitor resistance in a murine model of chronic lymphocytic leukemiaAnnika Scheffold, Billy Michael Chelliah Jebaraj, Eugen Tausch, et al.
Haematologica|November 10, 2018
The involvement of microRNA in the pathogenesis of Richter syndromeKatrien Van Roosbroeck, Recep Bayraktar, Steliana Calin, et al.
JCI Insight|February 1, 2017
Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinibJan A Burger, Kelvin W Li, Michael J Keating, et al.
Leukemia|May 3, 2021
Myeloid-derived suppressor cell subtypes differentially influence T-cell function, T-helper subset differentiation, and clinical course in CLLGerardo Ferrer, Byeongho Jung, Pui Yan Chiu, et al.
Pageof 4